Skip to main content

Table 1 Genetic status and p53-MCL rate of LCLs from familial breast and ovarian cancer

From: Detection of ATM germline variants by the p53 mitotic centrosomal localization test in BRCA1/2-negative patients with early-onset breast cancer

  BRCA1 BRCA2 CHK2 PALB2 ATM p53-MCL%
BR36 wt mut nt nt nt 80
BR13 wt mut nt nt nt 76
BR409-3 mut wt nt nt nt 97
BR324-1 mut wt nt nt nt 85
BR404-1 mut wt wt wt wt 76
BR317 mut wt nt nt mut 50
BR377 wt wt wt wt mut 50
BR60-1 wt wt wt wt wt 71
BR107-1 wt wt wt wt wt 90
BR362-1 wt wt wt wt wt 92
BR494 wt wt wt wt wt 86
BR38 wt wt wt wt wt 91
BR48 wt wt wt wt wt 70
BR278-1 wt wt wt wt wt 80
BR501 wt wt mut wt wt 80
  1. wt wild type, mut mutated, nt not tested